{"id":"https://openalex.org/W2151513445","doi":"https://doi.org/10.1186/1742-4690-7-78","title":"Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion","display_name":"Effect of a short-term HAART on SIV load in macaque tissues is dependent on time of initiation and antiviral diffusion","publication_year":2010,"publication_date":"2010-09-26","ids":{"openalex":"https://openalex.org/W2151513445","doi":"https://doi.org/10.1186/1742-4690-7-78","mag":"2151513445","pmid":"https://pubmed.ncbi.nlm.nih.gov/20868521","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2955669"},"language":"en","primary_location":{"id":"doi:10.1186/1742-4690-7-78","doi":"https://doi.org/10.1186/1742-4690-7-78","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-7-78","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-7-78","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2151513445"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-7-78","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5050040238","display_name":"Olivier Bourry","orcid":"https://orcid.org/0000-0003-0220-0922","observed_orcids":["https://orcid.org/0000-0003-0220-0922"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Olivier Bourry","raw_affiliation_strings":["CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080268881","display_name":"Abdelkrim Mannioui","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Abdelkrim Mannioui","raw_affiliation_strings":["CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Pierre Sellier","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]},{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210119095","display_name":"H\u00f4pital Lariboisi\u00e8re","ror":"https://ror.org/02mqtne57","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210119095"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Sellier","raw_affiliation_strings":["Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Lariboisi\u00e8re, 2 rue Ambroise Par\u00e9, 75010, Paris, France","CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Assistance Publique-H\u00f4pitaux de Paris, H\u00f4pital Lariboisi\u00e8re, 2 rue Ambroise Par\u00e9, 75010, Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210119095"]},{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079927319","display_name":"Camille Roucairol","orcid":"https://orcid.org/0009-0004-6364-8944","observed_orcids":["https://orcid.org/0009-0004-6364-8944"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Camille Roucairol","raw_affiliation_strings":["CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210128565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055899903","display_name":"Lucie Durand\u2010Gasselin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Lucie Durand-Gasselin","raw_affiliation_strings":["CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210128565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007314757","display_name":"Nathalie Dereuddre\u2010Bosquet","orcid":"https://orcid.org/0000-0001-6682-6313","observed_orcids":["https://orcid.org/0000-0001-6682-6313"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Nathalie Dereuddre-Bosquet","raw_affiliation_strings":["CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057863442","display_name":"Henri B\u00e9nech","orcid":"https://orcid.org/0000-0003-3181-3744","observed_orcids":["https://orcid.org/0000-0003-3181-3744"]},"institutions":[{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210128565","display_name":"CEA Paris-Saclay","ror":"https://ror.org/03n15ch10","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Henri Benech","raw_affiliation_strings":["CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Service de Pharmacologie et d'Immunoanalyse, DSV/iBiTecS, CEA/Saclay, 91191Gif-sur-Yvette, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210128565"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001404007","display_name":"Pierre Roques","orcid":"https://orcid.org/0000-0003-1825-1054","observed_orcids":["https://orcid.org/0000-0003-1825-1054"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Pierre Roques","raw_affiliation_strings":["CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032170909","display_name":"Roger Le Grand","orcid":"https://orcid.org/0000-0002-4928-4484","observed_orcids":["https://orcid.org/0000-0002-4928-4484"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2738703131","display_name":"Commissariat \u00e0 l'\u00c9nergie Atomique et aux \u00c9nergies Alternatives","ror":"https://ror.org/00jjx8s55","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131"]},{"id":"https://openalex.org/I4210097138","display_name":"CEA Paris-Saclay - Etablissement de Fontenay-aux-roses","ror":"https://ror.org/010j2gw05","country_code":"FR","type":"government","lineage":["https://openalex.org/I2738703131","https://openalex.org/I277688954","https://openalex.org/I4210097138","https://openalex.org/I4210128565"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Roger Le Grand","raw_affiliation_strings":["CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CEA, Division of Immuno-Virology, DSV/iMETI, Fontenay-aux-Roses, France","institution_ids":["https://openalex.org/I2738703131","https://openalex.org/I4210097138"]},{"raw_affiliation_string":"Universit\u00e9 Paris-Sud 11, UMR E01, Orsay, France","institution_ids":["https://openalex.org/I102197404"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5032170909"],"corresponding_institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2738703131","https://openalex.org/I4210097138"],"apc_list":{"value":2890,"currency":"USD","value_usd":2890},"apc_paid":{"value":2890,"currency":"USD","value_usd":2890},"fwci":1.636,"has_fulltext":true,"cited_by_count":67,"citation_normalized_percentile":{"value":0.80903491,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"7","issue":"1","first_page":"78","last_page":"78"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.004999999888241291,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.9169999957084656},{"id":"https://openalex.org/keywords/sivmac251","display_name":"SIVmac251","score":0.8119999766349792},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.6830000281333923},{"id":"https://openalex.org/keywords/treatment-timing","display_name":"treatment timing","score":0.5049999952316284},{"id":"https://openalex.org/keywords/post-exposure-prophylaxis","display_name":"post-exposure prophylaxis","score":0.8529999852180481},{"id":"https://openalex.org/keywords/tissue-viral-load","display_name":"tissue viral load","score":0.7120000123977661},{"id":"https://openalex.org/keywords/lymphoid-tissue","display_name":"lymphoid tissue","score":0.5139999985694885},{"id":"https://openalex.org/keywords/gut-associated-lymphoid-tissue","display_name":"gut-associated lymphoid tissue","score":0.9229999780654907},{"id":"https://openalex.org/keywords/zidovudine","display_name":"zidovudine","score":0.8190000057220459},{"id":"https://openalex.org/keywords/lamivudine","display_name":"lamivudine","score":0.9200000166893005},{"id":"https://openalex.org/keywords/didanosine","display_name":"didanosine","score":0.6620000004768372},{"id":"https://openalex.org/keywords/viral-dissemination","display_name":"viral dissemination","score":0.4790000021457672},{"id":"https://openalex.org/keywords/acute-infection","display_name":"acute infection","score":0.41100001335144043},{"id":"https://openalex.org/keywords/macaque-model","display_name":"macaque model","score":0.5440000295639038}],"concepts":[{"id":"https://openalex.org/C2778950215","wikidata":"https://www.wikidata.org/wiki/Q177601","display_name":"Macaque","level":2,"score":0.7237423062324524},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6611599326133728},{"id":"https://openalex.org/C2779175743","wikidata":"https://www.wikidata.org/wiki/Q156606","display_name":"Rhesus macaque","level":2,"score":0.633460521697998},{"id":"https://openalex.org/C61797465","wikidata":"https://www.wikidata.org/wiki/Q1188986","display_name":"Term (time)","level":2,"score":0.6091275215148926},{"id":"https://openalex.org/C2777995582","wikidata":"https://www.wikidata.org/wiki/Q1890246","display_name":"Simian immunodeficiency virus","level":3,"score":0.5892312526702881},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.561920166015625},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.524077832698822},{"id":"https://openalex.org/C69357855","wikidata":"https://www.wikidata.org/wiki/Q163214","display_name":"Diffusion","level":2,"score":0.47692081332206726},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.40239256620407104},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.35917162895202637},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3360680043697357},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.3307158052921295},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.1829822063446045},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.169888436794281},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.08001023530960083},{"id":"https://openalex.org/C97355855","wikidata":"https://www.wikidata.org/wiki/Q11473","display_name":"Thermodynamics","level":1,"score":0.0},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008252","descriptor_name":"Macaca fascicularis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014018","descriptor_name":"Tissue Distribution","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D014766","descriptor_name":"Viremia","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015215","descriptor_name":"Zidovudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015302","descriptor_name":"Simian Immunodeficiency Virus","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D016097","descriptor_name":"Simian Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016097","descriptor_name":"Simian Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D016097","descriptor_name":"Simian Acquired Immunodeficiency Syndrome","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018894","descriptor_name":"Reverse Transcriptase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019259","descriptor_name":"Lamivudine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019469","descriptor_name":"Indinavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1186/1742-4690-7-78","doi":"https://doi.org/10.1186/1742-4690-7-78","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-7-78","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-7-78","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},{"id":"pmid:20868521","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20868521","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2955669","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2955669/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"Text"},{"id":"pmh:oai:HAL:inserm-00668445v1","doi":null,"is_oa":true,"landing_page_url":"https://inserm.hal.science/inserm-00668445","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Retrovirology, 2010, 7 (1), pp.78. ⟨10.1186/1742-4690-7-78⟩","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:doaj.org/article:c68b4f467a58423da9a49c7ac4fc6efd","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/c68b4f467a58423da9a49c7ac4fc6efd","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Retrovirology, Vol 7, Iss 1, p 78 (2010)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/1742-4690-7-78","doi":"https://doi.org/10.1186/1742-4690-7-78","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1742-4690-7-78","pdf_url":"https://retrovirology.biomedcentral.com/counter/pdf/10.1186/1742-4690-7-78","source":{"id":"https://openalex.org/S54115554","display_name":"Retrovirology","issn_l":"1742-4690","issn":["1742-4690"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Retrovirology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2151513445.pdf","grobid_xml":"https://content.openalex.org/works/W2151513445.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W1963812842","https://openalex.org/W1965133362","https://openalex.org/W1967650255","https://openalex.org/W1975240882","https://openalex.org/W1984999783","https://openalex.org/W1992842828","https://openalex.org/W1993020322","https://openalex.org/W1994476715","https://openalex.org/W1995389281","https://openalex.org/W1999396723","https://openalex.org/W2009295277","https://openalex.org/W2012325453","https://openalex.org/W2017890292","https://openalex.org/W2018793167","https://openalex.org/W2019943079","https://openalex.org/W2027812093","https://openalex.org/W2043409853","https://openalex.org/W2046348452","https://openalex.org/W2046745323","https://openalex.org/W2050494263","https://openalex.org/W2057575510","https://openalex.org/W2065608903","https://openalex.org/W2066409312","https://openalex.org/W2067617284","https://openalex.org/W2071960376","https://openalex.org/W2078756383","https://openalex.org/W2094719216","https://openalex.org/W2103152015","https://openalex.org/W2107318515","https://openalex.org/W2114654929","https://openalex.org/W2139270639","https://openalex.org/W2152464646","https://openalex.org/W2329393410","https://openalex.org/W2332315389","https://openalex.org/W2340035478","https://openalex.org/W3124539787"],"related_works":["https://openalex.org/W7096984881","https://openalex.org/W2031019882","https://openalex.org/W2003037931","https://openalex.org/W1986079838","https://openalex.org/W4393233854","https://openalex.org/W2122725362","https://openalex.org/W1977412802","https://openalex.org/W2105028368","https://openalex.org/W2983794036","https://openalex.org/W2164458439"],"abstract_inverted_index":{"BACKGROUND:":[0],"HIV":[1,20,269],"reservoirs":[2,21],"are":[3],"rapidly":[4],"established":[5],"after":[6,96,137],"infection,":[7],"and":[8,72,74,123,161,175,263,271],"the":[9,32,39,55,76,138,157,162,183,205,213,225,229,235],"effect":[10,56,170],"of":[11,41,44,57,79,99,164,171,185,196,200],"HAART":[12,61],"initiated":[13,62,91,136],"very":[14],"early":[15,87,146],"during":[16,66,145],"acute":[17,67],"infection":[18,43,68,98,148],"on":[19,69,120,173],"remains":[22],"poorly":[23],"documented,":[24],"particularly":[25],"in":[26,51,125,156,188,204,212,224,228,238,251,260],"tissue":[27],"known":[28],"to":[29,49,268],"actively":[30],"replicate":[31],"virus.":[33],"In":[34,180],"this":[35],"context,":[36],"we":[37,84],"used":[38],"model":[40],"experimental":[42],"macaques":[45,100,166],"with":[46,89,101,193],"pathogenic":[47],"SIV":[48,121],"assess":[50],"different":[52,64],"tissues:":[53],"(i)":[54],"a":[58,104,117,168],"short":[59],"term":[60],"at":[63],"stages":[65],"viral":[70,153,258],"dissemination":[71,124],"replication,":[73],"(ii)":[75],"local":[77,194],"concentration":[78,223,232],"antiviral":[80,248],"drugs.":[81],"RESULTS:":[82],"Here,":[83],"show":[85],"that":[86,246],"treatment":[88,134,172],"AZT/3TC/IDV":[90],"either":[92],"within":[93],"4":[94],"hours":[95],"intravenous":[97],"SIVmac251":[102],"(as":[103],"post":[105],"exposure":[106],"prophylaxis)":[107],"or":[108,144],"before":[109],"viremia":[110,139,174],"peak":[111,140],"(7":[112],"days":[113,142,150],"post-infection":[114],"[pi]),":[115],"had":[116],"strong":[118,169],"impact":[119],"production":[122],"all":[126,239],"tissues":[127,189,240,254,262],"but":[128],"did":[129],"not":[130],"prevent":[131],"infection.":[132],"When":[133],"was":[135,190,233],"(14":[141],"pi)":[143],"chronic":[147],"(150":[149],"pi),":[151],"significant":[152],"replication":[154,259],"persists":[155],"peripheral":[158],"lymph":[159],"nodes":[160],"spleen":[163],"treated":[165],"despite":[167],"gut":[176,206],"associated":[177],"lymphoid":[178,215,253],"tissues.":[179,216],"these":[181,261],"animals,":[182],"level":[184],"virus":[186],"persistence":[187],"inversely":[191],"correlated":[192],"concentrations":[195,199,209],"3TC:":[197],"high":[198],"3TC":[201],"were":[202,210],"measured":[203],"whereas":[207],"low":[208],"observed":[211],"secondary":[214,252],"IDV,":[217],"like":[218],"3TC,":[219],"showed":[220],"much":[221],"higher":[222],"colon":[226],"than":[227],"spleen.":[230],"AZT":[231],"below":[234],"quantification":[236],"threshold":[237],"studied.":[241],"CONCLUSIONS:":[242],"Our":[243],"results":[244],"suggest":[245],"limited":[247],"drug":[249],"diffusion":[250],"may":[255],"allow":[256],"persistent":[257],"could":[264],"represent":[265],"an":[266],"obstacle":[267],"prevention":[270],"eradication.":[272]},"counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":10},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":8},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}